According to a recent industry report by Future Market Insights (FMI), the global multiplex biomarker imaging industry is projected to reach US$ 1,041.7 million by 2029, from an estimated US$ 475.2 million in 2022.
Over the course of the forecast period, the global multiplex biomarker imaging market is expected to grow significantly due to the growing need for advanced immunofluorescence techniques that help with better tumour detection and management at the cellular level, as per the report’s findings.
Multiplex biomarker imaging was estimated to be worth US$ 300 million in 2018 and is projected to expand at a compound annual growth rate (CAGR) of 12% between 2019 and 2029.
To Remain Ahead of Your Competitors, Request For A Sample! https://www.futuremarketinsights.com/reports/sample/rep-gb-3526
Key Takeaways of Multiplex Biomarker Imaging Market Study:
- There is steady demand for immunofluorescence slide scanners, as these offer exceptionally high image quality, reliability, and speed for whole slide imaging.
- North America is anticipated to be an attractive market for multiplex biomarker imaging, owing to developed healthcare infrastructure, favorable government policies, and financial grants for laboratory research by the government
- Immunostaining is widely used in the diagnosis of abnormal cells, such as cancerous cells, and also assists in understanding the distribution and localization of biomarkers and differentially expressed proteins in different parts of a biological tissue.
- The commercial success of the multiplex biomarkers imaging market is highly dependent on cancer research studies, which could serve multiple purposes such as detection of cancerous cells, presence of necrotic agents, and assessment of structural and functional abnormalities in cellular anatomy.
Tier 1 Players to Hold More Than 80% Revenue Share:
PerkinElmer, Bio-Rad, and Thermo Fisher Scientific are among the leading market players in the multiplex biomarker imaging market. These manufacturers continue to dominate the landscape of the multiplex biomarker imaging market due to their strong focus on product innovation, market leadership in product introduction, and strong distribution network with translational laboratories and academic institutes to increase sales.
Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/askus/rep-gb-3526
Want more insights?
Future Market Insights has studied the evolution of the multiplex biomarker imaging market from 2014–2018, and presents demand projections for 2019–2029, on the basis of component type (instruments, software, and services), imaging technique (IHC assays, FISH assays, TMA assays), application (research and clinical diagnostics), and end user (translational laboratories, biopharmaceutical companies, and academic institutes) across seven prominent regions.
Global Multiplex Biomarker Imaging Market: Regional Forecast:
Future Market Insights tracks the performance of the global multiplex biomarker imaging market across the key geographies of North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan, and Middle East and Africa. As per the forecast of Future Market Insights, the North America multiplex biomarker imaging market is estimated to be valued at US$ 152.4 Million in the year 2017 and is slated to touch a value of US$ 501.4 Million at the end of the year 2027 and exhibit a CAGR of 12.6% during the assessment period. The Western Europe multiplex biomarker imaging market is estimated to be valued at US$ 64.7 Million in the year 2017 and is poised to touch a value of US$ 208.6 Million at the end of the year 2027 and exhibit a CAGR of 12.4% during the period of assessment.
Global Multiplex Biomarker Imaging Market: Vendor Insights
The report has included some of the key players operating in the global multiplex biomarker imaging market such as Perkin Elmer, Inc., Bio-rad Laboratories Inc., Thermo Fisher Scientific, Inc., Abcam plc., Merck KGaA, Illumina Inc., Leica Biosystems Nussloch GmbH, Ventana Medical Systems, Inc., Aushon BioSystems Ltd., MicroConstants, Inc. and ToposNomos Ltd. Leading manufacturer of Multiplex Biomarker Imaging are focusing on collaborations with laboratories and biopharmaceutical companies in order to expand sales presence. Other companies are focusing on targeting technologically advanced emerging economies such as Asia Pacific region with availability of sufficient capital base and skilled labour.
Your Market, Your Insights: Request Customizations to Optimize Your Multiplex Biomarker Imaging Market Approach: https://www.futuremarketinsights.com/customization-available/rep-gb-3526
Multiplex Biomarker Imaging Market Taxonomy:
The global multiplex biomarker imaging market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to readers.
Component Type
- Instruments
- Quantitative Pathology Imaging Systems
- Immunofluorescence Slide Scanners
- Toponome Imaging Systems
- Multispectral Imaging Systems
- Software
- Services
- Installation & Integration Services
- Maintenance Services
Imaging Technique
- Immunohistochemistry (IHC) Assays
- Fluorescent In-Situ Hybridization (FISH) Assays
- Tissue Microarray (TMA) Assays
Application
- Research
- Clinical Diagnostics
End User
- Translation Laboratories
- Biopharmaceutical Companies
- Academic Institutes
Region
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan (APEJ)
- Japan
- Middle East and Africa
Gain Immediate Access to Detailed Market Insights: Purchase Now! https://www.futuremarketinsights.com/checkout/3526
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
